{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:00:51Z","timestamp":1791900051811,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.taap.2025.117696","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T07:56:51Z","timestamp":1766563011000},"page":"117696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dapagliflozin regulates kynurenine metabolism and microglial activation to alleviate diabetes-associated cognitive impairment"],"prefix":"10.1016","volume":"507","author":[{"given":"Yanhong","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangxia","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117696_bb0005","first-page":"452","article-title":"Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitis","volume":"125","author":"Ahlberg Weidenfors","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.taap.2025.117696_bb0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acschemneuro.0c00722","article-title":"Targeting ROS-dependent AKT\/GSK-3\u03b2\/NF-\u03baB and DJ-1\/Nrf2 pathways by dapagliflozin attenuates neuronal injury and motor dysfunction in rotenone-induced Parkinson's Disease Rat Model","volume":"12","author":"Arab","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.taap.2025.117696_bb0015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jchf.2025.03.014","article-title":"Rationale and design of the dapagliflozin effect on cardiovascular events in acute heart failure (DAPA ACT HF)-TIMI 68 trial","volume":"13","author":"Berg","year":"2025","journal-title":"JACC Heart Fail."},{"issue":"10","key":"10.1016\/j.taap.2025.117696_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.taap.2025.117696_bb0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","article-title":"Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective","volume":"19","author":"Biessels","year":"2020","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.taap.2025.117696_bb0030","article-title":"The mechanism of the neuroprotective effect of Kynurenic acid in the experimental model of neonatal hypoxia-ischemia: the link to oxidative stress","volume":"10","author":"Bratek-Gerej","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.taap.2025.117696_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1205834","article-title":"Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels","volume":"14","author":"Cai","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.taap.2025.117696_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70361","article-title":"Dapagliflozin improves high-fat diet-induced cognitive impairment in female mice","volume":"15","author":"Chen","year":"2025","journal-title":"Brain Behav."},{"issue":"12","key":"10.1016\/j.taap.2025.117696_bb0045","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.7150\/thno.106811","article-title":"Integrated cascade antioxidant nanozymes-cu(5.4)O@CNDs combat acute liver injury by regulating retinol metabolism","volume":"15","author":"Chen","year":"2025","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.taap.2025.117696_bb0050","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2213-8587(20)30162-5","article-title":"Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial","volume":"8","author":"Cherney","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.taap.2025.117696_bb0060","unstructured":"El-Rawy, A.F. 2025."},{"issue":"5","key":"10.1016\/j.taap.2025.117696_bb0055","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.immuni.2025.04.009","article-title":"Microglia transcriptional states and their functional significance: context drives diversity","volume":"58","author":"Depp","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.taap.2025.117696_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118076","article-title":"Dapagliflozin improves behavioral dysfunction of Huntington\u2019s disease in rats via inhibiting apoptosis-related glycolysis","volume":"257","author":"El-Sahar","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2025.117696_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107087","article-title":"The dangerous \u201cwest coast swing\u201d by hyperglycaemia and chronic stress in the mouse hippocampus: role of kynurenine catabolism","volume":"201","author":"Gliozzi","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117696_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/biof.1998","article-title":"Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice","volume":"50","author":"Gui","year":"2024","journal-title":"Biofactors"},{"issue":"7","key":"10.1016\/j.taap.2025.117696_bb0080","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/bph.17407","article-title":"Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine-3-monooxygenase with microglial decline","volume":"182","author":"Hasegawa","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117696_bb0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.freeradbiomed.2025.04.028","article-title":"Dapagliflozin attenuates diabetes-induced podocyte lipotoxicity via ERR\u03b1-mediated lipid metabolism","volume":"234","author":"Hu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.taap.2025.117696_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-025-00825-0","article-title":"Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research","volume":"20","author":"Jung","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"4\u20135","key":"10.1016\/j.taap.2025.117696_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14728222.2023.2206955","article-title":"Dapagliflozin modulates neuronal injury via instigation of LKB1\/p-AMPK\/GABAB R2 signaling pathway and suppression of the inflammatory cascade in an essential tremor rat model","volume":"27","author":"Kamel","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.taap.2025.117696_bb0100","first-page":"18","article-title":"Kynurenine pathway in epilepsy: unraveling its role in glutamate excitotoxicity, GABAergic dysregulation, neuroinflammation, and mitochondrial dysfunction","volume":"43","author":"Kaur","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.taap.2025.117696_bb0105","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-023-37170-z","article-title":"Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR\/PPAR\u03b3 signaling axis","volume":"14","author":"Kesarwani","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2025.117696_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564077","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"11","author":"Kinuthia","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.taap.2025.117696_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.taap.2025.117696_bb0120","first-page":"1429","article-title":"Neuropathological links between T2DM and LOAD: systematic review and meta-analysis","volume":"105","author":"Lemche","year":"2025","journal-title":"Meta-Analysis"},{"key":"10.1016\/j.taap.2025.117696_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.taap.2025.117696_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114117","article-title":"Dapagliflozin alleviated seizures and cognition impairment in pilocarpine induced status epilepticus via suppressing microglia-mediated neuroinflammation and oxidative stress","volume":"148","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2025.117696_bb0135","article-title":"Novel object recognition test for the investigation of learning and memory in mice","volume":"126","author":"Lueptow","year":"2017","journal-title":"J. Vis. Exp."},{"issue":"8","key":"10.1016\/j.taap.2025.117696_bb0140","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1111\/dom.16450","article-title":"Mechanisms of vascular endothelial cell injury triggered by blood glucose changes in gestational diabetes mellitus","volume":"27","author":"Mi","year":"2025","journal-title":"Diabetes, obesity & metabolism"},{"issue":"4","key":"10.1016\/j.taap.2025.117696_bb0145","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic acid in schizophrenia: a systematic review and meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.taap.2025.117696_bb0150","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40264-014-0213-4","article-title":"Safety profile of Dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events","volume":"37","author":"Ptaszynska","year":"2014","journal-title":"Drug Saf."},{"key":"10.1016\/j.taap.2025.117696_bb0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuro.2015.08.003","article-title":"Mitochondrial dysfunction related to cell damage induced by 3-hydroxykynurenine and 3-hydroxyanthranilic acid: non-dependent-effect of early reactive oxygen species production","volume":"50","author":"Reyes-Ocampo","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2025.117696_bb0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","article-title":"SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats","volume":"333","author":"Sa-nguanmoo","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117696_bb0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12916-025-04018-w","article-title":"The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis","volume":"23","author":"Tseng","year":"2025","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.taap.2025.117696_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12974-023-02740-x","article-title":"Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies","volume":"20","author":"Vargas-Soria","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.taap.2025.117696_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41398-025-03378-4","article-title":"Antidepressant effects of ershiwei roudoukou pills and its active ingredient Macelignan: Multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity","volume":"15","author":"Wang","year":"2025","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.taap.2025.117696_bb0180","article-title":"Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.taap.2025.117696_bb0185","series-title":"Immune-Vascular Synergy: A Photodynamic Hydrogel Activating ALDH2 to Combat Inflammation and Enhance Angiogenesis in Diabetic Wound Healing","author":"Xiong","year":"2025"},{"issue":"4","key":"10.1016\/j.taap.2025.117696_bb0190","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5497","article-title":"Transcriptomics and proteomics characterizing the antioxidant mechanisms of semaglutide in diabetic mice with cognitive impairment","volume":"55","author":"Yang","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.taap.2025.117696_bb0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/NRR.NRR-D-24-00777","article-title":"Tryptophan metabolism and ischemic stroke: an intricate balance","volume":"21","author":"Yao","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.taap.2025.117696_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111824","article-title":"Dapagliflozin activates the RAP1B\/NRF2\/GPX4 signaling and promotes mitochondrial biogenesis to alleviate vascular endothelial ferroptosis","volume":"132","author":"Zhu","year":"2025","journal-title":"Cell. Signal."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:35:22Z","timestamp":1769103322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25004727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"alternative-id":["S0041008X25004727"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117696","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin regulates kynurenine metabolism and microglial activation to alleviate diabetes-associated cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117696"}}